Amplified Sciences

company

About

Amplified Sciences is a life science diagnostics company focused on accurately detecting and pre-empting the risks of debilitating diseases.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$1M
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Amplified Sciences is a molecular diagnostics company unlike other diagnostics companies due to their ultra-sensitive molecular sensing technology with composition of matter IP exclusively licensed from Purdue University. The technology is disease state agnostic, can detect to the single molecule level, scales easily to point of care, and provides a very favorable cost structure for their platform of reagents. The first application – early detection of pancreatic cancer - is an assay that will quickly prove the investment thesis due to large unmet medical need and a favorable reimbursement path. The team has delivered a working prototype and published proof of concept data.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1M
Amplified Sciences has raised a total of $1M in funding over 2 rounds. Their latest funding was raised on Apr 24, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 24, 2020 Seed $1M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Amplified Sciences is funded by 1 investors. Indiana University Philanthropic Venture Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Indiana University Philanthropic Venture Fund Seed